Skip to content

Effects of combined percutaneous epidural adhesiolysis and balloon decompression

Effects of combined percutaneous epidural adhesiolysis and balloon decompression in patients with refractory chronic low back and leg pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002280
Enrollment
457
Registered
2017-03-28
Start date
2015-07-20
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who visited pain clinic complained of lumbar radicular pain with or without lower back pain and the patients who agree to participating in this study. 2. Adults patients over 20 years old. 3. The patients with chronic (at least 3 months) lumbar radicular pain with or without lower back pain 4. The history, clinical symptoms, lumbar magnetic resonance imaging (MRI) findings, and epidurogram revealed that filling defect was consistent with lesion. 5. Refractory to conservative treatment (above 3 months) 6. Patients who did not have pain relief for more than 1 month after epidural steroid injection or transforaminal epidural steroid injection as 1st line treatment. 7. Patients who have voluntarily agreed in writing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. The patient does not agree to participate in the study 2. Pregnant or lactating patients 3. Side effects on topical anesthetics or steroids 4. unbearable pain, NRS 10 5. Red flag sign such as infection, cancer, neurologic deficit, and newly developed severe medical problem. 6. Yellow flag (depression, anxiety, somatization, hypochondriasis, sue, claims) 7. Uncontrolled medical condition

Design outcomes

Primary

MeasureTime frame
Numerical Rating scale;Os-Westry functional scale;7-ponit scale global perceived effect of satisfaction

Secondary

MeasureTime frame
medication quantification scale III (MQS)

Countries

Korea, Republic of

Contacts

Public ContactJun Young Park

Asan Medical Center

parkjy@amc.seoul.kr+82-2-3010-3868

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026